RabAvert®

For preexposure administration, RABAVERT is contraindicated for persons who have had a severe allergic reaction (eg, anaphylaxis) after a previous dose of RABAVERT

...continue reading

RABAVERT is a registered trademark of the GSK group of companies.

References

"toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"View all references

400501R0 November 2015